The Dengvaxia mess in the Philippines is still actively evolving, but the vaccine’s maker Sanofi, with seemingly unyielding faith in its safety and efficacy, will soon decide whether to file for approval in the U.S.Original Article
Sanofi won’t let Philippines Dengvaxia mess deter it from seeking U.S. approval: report
